Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient

Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient

Peritoneal carcinosis (PC) is characterized by poor prognosis. PC is currently treated as a locoregional disease and the possibility to perform very precise treatments such as stereotactic body radiation therapy (SBRT) has opened up new therapeutic perspectives. More recently, the introduction of Ma...

Full description

Bibliographic Details
Main Authors:	Luca Boldrini, Angela Romano, Lorenzo Placidi, Gian Carlo Mattiucci, Giuditta Chiloiro, Davide Cusumano, Veronica Pollutri, Marco Valerio Antonelli, Luca Indovina, Maria Antonietta Gambacorta, Vincenzo Valentini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Oncology
Subjects:	online adaptive radiation therapy oligometastatic disease stereotactic body radiation therapy magnetic resonance guided radiation therapy peritoneal metastases colorectal cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2020.601739/full

Similar Items

Stereotactic body radiation therapy in patients with liver oligometastases from colorectal cancer: a systematic review
by: A. N. Moskalenko, et al.
Published: (2022-04-01)

Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer
by: Nima Aghdam, et al.
Published: (2020-12-01)

Mesorectal motion evaluation in rectal cancer MR-guided radiotherapy: an exploratory study to quantify treatment margins
by: Luca Boldrini, et al.
Published: (2023-01-01)

On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations
by: Lorenzo Placidi, et al.
Published: (2020-09-01)

CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
by: Michael Waters, et al.
Published: (2024-01-01)

On-line adaptive and real-time intrafraction motion management of spine-SBRT on an MR-linac
by: Justine M. Cunningham, et al.
Published: (2022-08-01)

Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer
by: D. Baron, et al.
Published: (2023-11-01)

Stereotactic body radiation therapy to postpone systemic therapy escalation for castration-resistant prostate cancer: A multicenter retrospective analysis
by: D. Baron, et al.
Published: (2024-03-01)

A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer
by: Xin Wang, et al.
Published: (2018-10-01)

A new method to visualize and to spare the ureters during SBRT for oligo metastatic patients
by: Emilien Muggeo-Bertin, et al.
Published: (2021-09-01)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
by: Rupesh Kotecha, et al.
Published: (2021-09-01)

MR-guided stereotactic body radiation therapy for primary cardiac sarcomas
by: Stefanie Corradini, et al.
Published: (2021-03-01)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
by: Cyrielle Scouarnec, et al.
Published: (2019-08-01)

MR-Guided Radiotherapy for Liver Malignancies
by: Luca Boldrini, et al.
Published: (2021-04-01)

Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center
by: Thomas Leroy, et al.
Published: (2017-06-01)

Dosimetric comparison in sparing normal tissue dosage by using auto-SBRT planning in oligo liver tumors
by: Shu Zhang, et al.
Published: (2023-11-01)

Influence of Dexamethasone Premedication on Acute Lung Toxicity in Lung SBRT
by: Fiori Alite, et al.
Published: (2022-02-01)

Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung Cancer and Melanoma: A Systematic Review
by: María Rodríguez Plá, et al.
Published: (2021-10-01)

Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature
by: M. Terlizzi, et al.
Published: (2023-03-01)

Progress in Oligometastatic Prostate Cancer: Emerging Imaging Innovations and Therapeutic Approaches
by: Ryo Oka, et al.
Published: (2024-01-01)

Do We Have a Winner? Advocating for SBRT in HCC Management
by: Amir H. Safavi, et al.
Published: (2024-03-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer
by: Robert eMeier
Published: (2015-04-01)

Ventricular tachycardia ablation through radiation therapy (VT-ART) consortium: Concept description of an observational multicentric trial via matched pair analysis
by: Francesco Cellini, et al.
Published: (2023-02-01)

Cellular Damage in the Target and Out-Of-Field Peripheral Organs during VMAT SBRT Prostate Radiotherapy: An In Vitro Phantom-Based Study
by: Igor Piotrowski, et al.
Published: (2022-05-01)

Oligometastasis: Expansion of Curative Treatments in the Field of Oncology
by: Ah Reum Lim, et al.
Published: (2023-11-01)

Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review
by: Salvatore Cozzi, et al.
Published: (2022-05-01)

Incidence of pain flare in radiation treatment of bone metastases: A literature review
by: Rachel McDonald, et al.
Published: (2014-11-01)

Role of Consolidative Stereotactic Body Radiation Therapy in Oligoresistant/Oligoprogressive Pulmonary Parenchymal Metastases
by: Berber T, et al.
Published: (2022-08-01)

The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy
by: Vinicius Ernani, et al.
Published: (2020-01-01)

THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis
by: Giuditta Chiloiro, et al.
Published: (2023-10-01)

Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
by: Karam Khaddour, et al.
Published: (2023-09-01)

Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases
by: Matthew Mills, et al.
Published: (2024-03-01)

Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial
by: David M. Routman, et al.
Published: (2024-03-01)

Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
by: Paulina M. Gutkin, et al.
Published: (2023-03-01)

Changing paradigm of radiation therapy for the treatment of pancreatic cancer
by: Beth K Neilsen, et al.
Published: (2019-12-01)

A Phase II Trial of SABR (Stereotactic Ablative Body Radiotherapy) for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life and Disease Control Outcomes with 5-Year Minimum Followup
by: Constantine Anastasios Mantz
Published: (2014-11-01)

Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy
by: Chi-Leung Chiang, et al.
Published: (2019-11-01)

Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)
by: Jing Sun, et al.
Published: (2019-08-01)

Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy
by: Yanhong Shi, et al.
Published: (2023-08-01)